| Typicality: | 0.424 |
| Saliency: | 0.181 |
| usually | 4 | degree |
| in the alemtuzumab-treated patients | 2 | other |
| infection → be → infrequent | 9 |
| negative | neutral | positive |
| 0.388 | 0.503 | 0.109 |
| Raw frequency | 9 |
| Normalized frequency | 0.181 |
| Modifier score | 0.800 |
| Perplexity | 56.475 |